On the other hand, Biogen has its roots in a Cambridge start - up founded in 1978 by MIT and Harvard scientists working in small, separate
labs on then - radical theories, pursuing research dead ends and racking up debt until blockbuster drugs for treating leukemia, MS, and non-Hodgkin's lymphoma brought
major commercial success.